{"id":1200,"date":"2024-12-23T10:01:43","date_gmt":"2024-12-23T01:01:43","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/?page_id=1200"},"modified":"2024-12-26T11:37:58","modified_gmt":"2024-12-26T02:37:58","slug":"2024-2","status":"publish","type":"page","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/2024-2\/","title":{"rendered":"2024"},"content":{"rendered":"\n

\uff08\u539f\u8457\u8ad6\u6587\uff09<\/strong><\/p>\n

    \n
  1. Otani T*, Moriguchi-Goto S*, Nishihira K, Oguri N, Shibata Y, Matsuura Y, Kodama T, Asada Y, Hatakeyama K,\u00a0Yamashita A. Intralesional pentraxin 3 increases with atherosclerotic disease progression, but may protect from thrombosis: Friend or foe? Thromb Res. 2024;234:134-141.\u00a0*Equally contributed. <\/strong>https:\/\/doi.org\/10.1016\/j.thromres.2024.01.004<\/a><\/li>\n
  2. Sugita C*, Maekawa K*, Gi T, Oguri N, Nakamura E, Furukoji E, Azuma M, Asada Y,\u00a0Yamashita A. Elevated plasma levels of factor VIII enhance arterial thrombus formation on erosive smooth muscle cell-rich neointima but not normal intima in rabbits. Thromb Res. 2024;238:185-196. *Equally contributed. <\/strong>https:\/\/doi.org\/10.1016\/j.thromres.2024.04.025<\/a><\/li>\n
  3. Oguri N*, Gi T*, Nakamura E, Furukoji E, Goto H, Maekawa K, Tsuji AB, Nishii R, Aman M, Moriguchi-Goto S, Sakae T, Azuma M, Yamashita A. Expression of fibroblast activation protein-\u03b1 in human deep vein thrombosis. Thromb Res. 2024;241:109075. *Equally contributed. <\/strong>https:\/\/doi.org\/10.1016\/j.thromres.2024.109075<\/a><\/li>\n<\/ol>\n

    \uff08\u75c7\u4f8b\u5831\u544a\uff09<\/strong><\/p>\n

      \n
    1. Uchida A, Matsuura Y, Kuroiwa Y, Kaikita K. Non-Contrast magnetic resonance imaging of isolated superior mesenteric artery dissection. Circ Rep. 2024;6:34-35.<\/li>\n
    2. Fujimoto K, Hisanaga S, Kuroda S, Kodama K, Sugiyama F, Kikuchi M, Kita T,\u00a0Yamashita A, Nagai T, Kamimura T, Kaikita K, Imamura T, Fujimoto S. A case of primary aldosteronism with excessive secretion of renin that was unmasked by kidney transplantation. CEN Case Rep. 2024;13:1-8.\u00a0<\/li>\n
    3. Nishino S, Nishimura M, Asada Y,\u00a0Yamashita A, Shibata Y. Progressive worsening of aortic regurgitation due to detachment of the aortic valve commissure with multimodality imaging to elucidate pathogenesis: a case report. Eur Heart J Case Rep. 2024;8:ytae178\u00a0<\/li>\n
    4. Kawaguchi T, Kitamura A, Kimura M, Rikitake Y, Iwao C, Iwao K, Sumiyoshi M, Kariya Y, Matsuda M, Umekita K, Takajo I, Moriguchi-Goto S,\u00a0Yamashita A, Matsumoto K, Miyazaki T. Successful treatment of disseminated cryptococcosis with liposomal amphotericin B and isavuconazole in an adult living with HIV: A case report and literature review. J Infect Chemother. 2024:S1341-321X(24)00275-7.\u00a0<\/li>\n
    5. Murashima T, Kida K, Gi T, Hida T, Fujii M, Nagai T, Takamori H, Mukai S, Sato Y, Kamoto T. Paratesticular cellular angiofibroma: a case report. J Med Case Rep. 2024;18:170.<\/li>\n
    6. Yamada R, Oguri N, Kawano F, Inomata M, Sato Y, Maeda R. Primary pulmonary colloid adenocarcinoma: A case report of a rare subtype. Int J Surg Case Rep. 2024;123:110260.<\/li>\n
    7. \u9ed2\u6728\u9ebb\u7531, \u5927\u6817\u4f38\u884c, \u4e2d\u6751\u6075\u7406\u5b50, \u5742\u53e3\u4fee\u5e73, \u9b4f\u3000\u5cfb\u6d38, \u963f\u842c\u7d2b, \u76db\u53e3\u6df8\u9999, \u53e4\u5ddd\u8ca2\u4e4b, \u4f50\u85e4\u52c7\u4e00\u90ce, \u5c71\u4e0b\u7be4. \u50e7\u5e3d\u5f01\u5f62\u6210\u8853\u306b\u95a2\u9023\u3057\u305f\u5de6\u5ba4mesothelial\/monocytic incidental cardiac excrescence\u306e\u4e00\u4f8b. \u8a3a\u65ad\u75c5\u7406. 2024;42:343-348.<\/li>\n
    8. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u963f\u842c\u3000\u7d2b\u3001\u76db\u53e3\u6df8\u9999\u3001\u5e73\u7530\u3000\u5fb9\u3001\u5f8c\u85e4\u88d5\u9ebf\u3001\u6842\u6728\u771f\u53f8\u3001\u5185\u819c\u751f\u691c\u3067p53\u7570\u5e38\u306e\u817a\u764c\u3092\u7591\u3063\u305f\u764c\u8089\u816b\u306e1\u4f8b\u3001\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a\u8a8c. Vol.15: No.2: 71-73<\/li>\n<\/ol>\n

      \uff08\u7dcf\u8aac\u306a\u3069\uff09<\/strong><\/p>\n

        \n
      1. \u5c71\u4e0b\u3000\u7be4. \u30ab\u30e9\u30fc\u56f3\u8aac\uff1a\u8840\u6813\u5f62\u6210\u306e\u30e1\u30ab\u30cb\u30ba\u30e0. \u65e5\u672c\u81e8\u5e8a\u3000\u7279\u96c6 \u8840\u6813\u30fb\u585e\u6813\u75c7\u306e\u81e8\u5e8a. 2024;82:126-132.<\/li>\n
      2. \u5c71\u4e0b\u3000\u7be4. \u9759\u8108\u8840\u6813\u75c7\u306e\u767a\u75c7\u8981\u56e0 \u8840\u6d41\u3046\u3063\u6ede. \u65e5\u672c\u81e8\u5e8a\u3000\u5897\u520a\u53f7\u3000\u52d5\u8108\u30fb\u9759\u8108\u306e\u75be\u60a32024 (\u4e0a). 2024;82\u5897\u520a\u53f74:77-84.<\/li>\n
      3. \u5c71\u4e0b\u3000\u7be4. \u6b62\u8840\u30fb\u9759\u8108\u8840\u6813\u5f62\u6210\u6a5f\u5e8f up to date. \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a\u8a8c. 2024;48:117-21.<\/li>\n
      4. \u9b4f\u3000\u5cfb\u6d38. \u304c\u3093\u95a2\u9023\u9759\u8108\u8840\u6813\u585e\u6813\u306b\u304a\u3051\u308b\u8840\u6813\u5185\u304c\u3093\u7d30\u80de\u306e\u5b58\u5728. \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u8a8c. 2024;35:512-521.<\/li>\n
      5. \u9b4f\u3000\u5cfb\u6d38. \u80ba\u8840\u6813\u75c7\u306e\u75c5\u7406. \u75c5\u7406\u3068\u81e8\u5e8a. 2024;42:883-891.<\/li>\n
      6. \u82e5\u72ed\u3000\u670b\u5b50, \u963f\u842c\u3000\u7d2b. \u7f8a\u6c34\u585e\u6813\u75c7\u306e\u75c5\u7406. \u75c5\u7406\u3068\u81e8\u5e8a. 2024;42:892-898.<\/li>\n
      7. \u5c71\u4e0b\u3000\u7be4. \u8840\u6813\u75c7\u306e\u767a\u75c7\u3068\u8840\u6813\u5f62\u6210\u6a5f\u5e8f. \u75c5\u7406\u3068\u81e8\u5e8a. 2024;42:909-917.<\/li>\n<\/ol>\n

        \uff08\u5b66\u4f1a\u767a\u8868\uff09<\/strong><\/p>\n

          \n
        1. \u5800\u5185\u65e9\u7d00\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u963f\u842c\u3000\u7d2b\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u5c71\u4e0b\u3000\u7be4. \u51a0\u52d5\u8108\u786c\u5316\u5de3\u306b\u304a\u3051\u308b\u30d5\u30a3\u30d6\u30ea\u30f3\u30fb\u30d5\u30a9\u30f3\u30a6\u30a3\u30eb\u30d6\u30e9\u30f3\u30c9\u56e0\u5b50\u306e\u767a\u73fe\u3068\u597d\u4e2d\u7403\u7d30\u80de\u5916\u30c8\u30e9\u30c3\u30d7\u306e\u5f62\u6210. \u7b2c113\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a (\u540d\u53e4\u5c4b, 3\/28-30, 2024)<\/li>\n
        2. \u963f\u842c\u3000\u7d2b\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u5c71\u4e0b\u3000\u7be4.\u3000\u7652\u7740\u80ce\u76e4\u306b\u304a\u3051\u308bPAR-1\u767a\u73fe\u304a\u3088\u3073\u305d\u306e\u6d3b\u6027\u5316\u56e0\u5b50\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c113\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a (\u540d\u53e4\u5c4b, 3\/28-30, 2024)<\/li>\n
        3. \u5fb3\u6e80\u8cb4\u5b50\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u767d\u6ff1\u5e78\u751f\u3001\u5cf0\u677e\u6620\u5b50\u3001\u68ee\u7530\u52dd\u4ee3\u3001\u9ed2\u6728\u5948\u745e\u83dc\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u76db\u53e3\u6df8\u9999\u3001\u4e2d\u6751\u9999\u7e54\u3001\u897f\u5d0e\u51cc\u6b21\uff0e\u80c6\u6c41\u7d30\u80de\u8a3a\u306b\u304a\u3051\u308bLiquid based cytology: ThinPrep\u6cd5\uff0e\u7b2c65\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u7dcf\u4f1a\u6625\u671f\u5927\u4f1a\uff08\u5927\u962a\u56fd\u969b\u4f1a\u8b70\u5834\u30016\/7-9, 2024\uff09<\/li>\n
        4. \u5927\u6817\u4f38\u884c\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u53e4\u5c0f\u8def\u82f1\u4e8c\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u8fbb\u3000\u539a\u81f3\u3001\u897f\u4e95\u9f8d\u4e00\u3001\u69ae\u3000\u5efa\u6587\u3001\u6771\u7f8e\u83dc\u5b50\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u5c71\u4e0b\u3000\u7be4. \u6df1\u90e8\u9759\u8108\u8840\u6813\u306b\u304a\u3051\u308bfibroblast activating protein-\u03b1\u306e\u767a\u73fe. \u7b2c46\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\uff08\u91d1\u6ca2\u5e02\u30016\/13-15, 2024\uff09<\/li>\n
        5. Nakamura E, Horiuchi S, Maekawa K, Oguri N, Gi T, Moriguchi-Goto S, Aman M, Asada Y, Yamashita A. Fibrin and von Willebrand factor deposition, and neutrophil extracellular traps formation during human coronary atherogenesis. 32th Congress of International Society on Thrombosis and Haemostasis (Bangkok, 22-26. June. 2024)<\/li>\n
        6. Aman M, Sato Y, Asada Y, Yamashita A. The expression of PAR-1 and its activators in placenta accreta spectrum. 32th Congress of International Society on Thrombosis and Haemostasis (Bangkok, 22-26. June. 2024)<\/li>\n
        7. \u4e2d\u6751\u6075\u7406\u5b50\u3001\u5800\u5185\u65e9\u7d00\u3001\u76db\u53e3\u6df8\u9999\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u5c71\u4e0b\u3000\u7be4. \u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306b\u304a\u3051\u308b\u30d5\u30a3\u30d6\u30ea\u30f3\u30fb\u30d5\u30a9\u30f3\u30a6\u30a3\u30eb\u30d6\u30e9\u30f3\u30c9\u56e0\u5b50\u306e\u767a\u73fe\u3068\u597d\u4e2d\u7403\u7d30\u80de\u5916\u30c8\u30e9\u30c3\u30d7\u306e\u5f62\u6210\uff1a\u52d5\u8108\u786c\u5316\u9032\u5c55\u3068\u306e\u95a2\u9023. \u7b2c56\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\uff08\u795e\u6238\u56fd\u969b\u4f1a\u8b70\u5834\u30017\/6-7, 2024\uff09<\/li>\n
        8. \u9ed2\u5ca9\u9756\u6df3\u3001\u5185\u7530\u6681\u5b50\u3001\u571f\u80a5\u7701\u543e\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u6960\u5143\u5bff\u5178\u3001\u53e4\u5c0f\u8def\u82f1\u4e8c\u3001\u6728\u539f\u3000\u5eb7\u3001\u4eca\u6751\u5353\u90ce\u3001\u6771\u3000\u7f8e\u83dc\u5b50\u3001\u6d77\u5317\u5e78\u4e00\u3001\u5c71\u4e0b\u3000\u7be4. \u975e\u30a2\u30eb\u30b3\u30fc\u30eb\u6027\u8102\u80aa\u6027\u809d\u75be\u60a3\u306e\u65b0\u898f\u753b\u50cf\u8a3a\u65ad\uff1a\u6838\u78c1\u6c17\u5171\u9cf4\u753b\u50cf\u306b\u3088\u308b\u8179\u90e8\u5927\u52d5\u8108\u786c\u5316\u306e\u691c\u51fa\u3068\u809d\u81d3\u8a55\u4fa1. \u7b2c56\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\uff08\u795e\u6238\u56fd\u969b\u4f1a\u8b70\u5834\u30017\/6-7, 2024\uff09<\/li>\n
        9. \u5185\u7530\u6681\u5b50. MRI T1\u5f37\u8abf\u753b\u50cf\u304c\u793a\u3059\u9ad8\u4fe1\u53f7\u30d7\u30e9\u30fc\u30af\u306e\u7814\u7a76. Miyazaki Cardiologist Workshop 2024. (\u5bae\u5d0e, 7\/17, 2024)<\/li>\n
        10. \u4f50\u85e4\u611b\u7d50\u3001\u4eca\u6751\u7d18\u5b50\u3001\u85e4\u7384\u4e00\u90ce\u3001\u7530\u4e2d\u5927\u8cb4\u3001\u7d30\u5ddd\u7fa9\u5f66\u3001\u9ad8\u6751\u4e00\u7d18\u3001\u8c37\u53e3\u79c0\u4e00\u3001\u963f\u842c\u3000\u7d2b\u3001\u5d8b\u672c\u5bcc\u535a. Mature cystic teratoma\u306bependymoma\u3092\u5408\u4f75\u3057\u305f\u3068\u8003\u3048\u3089\u308c\u308b\u4e00\u4f8b. \u7b2c66\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a (\u9e7f\u5150\u5cf6\u30017\/18-20. 2024)<\/li>\n
        11. \u767d\u6ff1\u5e78\u751f\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u5fb3\u6e80\u8cb4\u5b50\u3001\u68ee\u7530\u52dd\u4ee3\u3001\u5cf0\u677e\u6620\u5b50\u3001\u9ed2\u6728\u5948\u745e\u83dc\u3001\u9f4b\u85e4\u5b09\u548c\u3001\u6885\u5317\u4f73\u5b50\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u76db\u53e3\u6df8\u9999\uff0eROSE\u306b\u304a\u3051\u308b\u80ba\u5c0f\u7d30\u80de\u764c\u3068\u975e\u5c0f\u7d30\u80de\u764c\u3068\u306e\u9451\u5225\u6240\u898b\u306b\u3064\u3044\u3066\uff0e\u7b2c63\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a\uff08\u5e55\u5f35\u30e1\u30c3\u30bb\u56fd\u969b\u4f1a\u8b70\u5834\u300111\/16-17, 2024\uff09<\/li>\n
        12. \u91ce\u53e3\u88d5\u53f2\u3001\u5fb3\u6e80\u8cb4\u5b50\u3001\u767d\u6ff1\u5e78\u751f\u3001\u68ee\u7530\u52dd\u4ee3\u3001\u5cf0\u677e\u6620\u5b50\u3001\u9ed2\u6728\u5948\u745e\u83dc\u3001\u9f4b\u85e4\u5b09\u548c\u3001\u6885\u5317\u4f73\u5b50\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u76db\u53e3\u6df8\u9999\uff0e\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\uff08Grade1-2\uff09\u3068\u53cd\u5fdc\u6027\u6ffe\u80de\u904e\u5f62\u6210\u306e\u9451\u5225\u3067\u30ad\u30fc\u30dd\u30a4\u30f3\u30c8\u306b\u306a\u308b\u7d30\u80de\u6240\u898b(\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\uff1a\u30ea\u30f3\u30d1\u816b\u30fb\u975e\u816b\u760d\u6027\u75c5\u5909\u306e\u9451\u5225\u3067\u30ad\u30fc\u30dd\u30a4\u30f3\u30c8\u306b\u306a\u308b\u7d30\u80de\u6240\u898b). \u7b2c63\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a\uff08\u5e55\u5f35\u30e1\u30c3\u30bb\u56fd\u969b\u4f1a\u8b70\u5834\u300111\/16-17, 2024\uff09<\/li>\n
        13. \u4e2d\u6751\u6075\u7406\u5b50\u3001\u5800\u5185\u65e9\u7d00\u3001\u76db\u53e3\u6df8\u9999\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u5c71\u4e0b\u3000\u7be4. \u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306e\u9032\u5c55\u306b\u304a\u3051\u308b\u597d\u4e2d\u7403\u7d30\u80de\u5916\u30c8\u30e9\u30c3\u30d7\u3001\u30d5\u30a3\u30d6\u30ea\u30f3\u3001\u30d5\u30a9\u30f3\u30a6\u30a3\u30eb\u30d6\u30e9\u30f3\u30c9\u56e0\u5b50\u306e\u5c40\u5728\u3068\u5e83\u304c\u308a. \u7b2c29\u56de\u65e5\u672c\u8840\u7ba1\u75c5\u7406\u7814\u7a76\u4f1a (\u798f\u5ca1\u300111\/23-24, 2024)<\/li>\n
        14. \u5927\u6817\u4f38\u884c\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u53e4\u5c0f\u8def\u82f1\u4e8c\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u8fbb\u3000\u539a\u81f3\u3001\u897f\u4e95\u9f8d\u4e00\u3001\u69ae\u3000\u5efa\u6587\u3001\u6771\u7f8e\u83dc\u5b50\u3001\u5c71\u4e0b\u3000\u7be4. \u6df1\u90e8\u9759\u8108\u8840\u6813\u306b\u304a\u3051\u308bfibroblast activating protein-\u03b1\u306e\u767a\u73fe\u3068\u305d\u306e\u6a5f\u80fd. \u7b2c29\u56de\u65e5\u672c\u8840\u7ba1\u75c5\u7406\u7814\u7a76\u4f1a (\u798f\u5ca1\u300111\/23-24, 2024)<\/li>\n
        15. \u68ee\u3000\u5922\u5b9f\u3001\u6c34\u5149\u6d0b\u8f14\u3001\u68da\u6a4b\u5229\u8cbb\u3001\u5185\u7530\u6681\u5b50\u3001\u5c71\u672c\u7d17\u5b50\u3001\u7530\u4e2d\u6d69\u559c\u3001\u5c0f\u7267\u8061\u4e00\u3001\u5c71\u53e3\u660c\u5fd7\u3001\u68ee\u6797\u8015\u5e73\u3001\u4e95\u624b\u53e3\u6b66\u53f2\u3001\u677e\u6d66\u7950\u4e4b\u4ecb\u3001\u9db4\u7530\u654f\u535a\u3001\u6d77\u5317\u5e78\u4e00. \u8840\u7ba1\u5468\u56f2\u306b\u9650\u5c40\u7684\u306a\u30a2\u30df\u30ed\u30a4\u30c9\u6c88\u7740\u3092\u8a8d\u3081\u3001\u51a0\u5fae\u5c0f\u5faa\u74b0\u969c\u5bb3\u3092\u5448\u3057\u305fATTR\u578b\u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u4e00\u4f8b. \u7b2c137\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a (\u5225\u5e9c\u300112\/14, 2024)<\/li>\n
        16. \u6d25\u5b88\u5bb9\u5b50\u3001\u6e05 \u771f\u7531\u7f8e\u3001\u9b3c\u585a\u4e45\u5145\u3001\u6e21\u908a\u73b2\u5b50\u3001\u677e\u5c3e\u525b\u5fd7\u3001\u5150\u7389\u7434\u5b50\u3001\u5ca9\u576a\u4fee\u53f8\u3001\u7dd2\u65b9\u5065\u4e8c\u3001\u6728\u6751\u4fca\u4e4b\u3001\u67f4\u7530\u525b\u5fb3\u3001\u9ed2\u6728\u6075\u7f8e\u3001\u68ee\u3000\u6643\u4f51\u3001\u53e4\u5ddd\u8ca2\u4e4b\u3001\u5927\u6817\u4f38\u884c\u3001\u5c71\u4e0b\u3000\u7be4. 3\u5e74\u9593\u3067\u91cd\u75c7\u306e\u50e7\u5e3d\u5f01\u72ed\u7a84\u75c7\u306b\u9032\u884c\u3057\u305f\u7dad\u6301\u8840\u6db2\u900f\u6790\u60a3\u8005\u306e\u4e00\u4f8b. \u7b2c137\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a\uff08\u5225\u5e9c\u5e02\u300112\/14, 2024\uff09<\/li>\n<\/ol>\n

          \uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u306a\u3069\uff09<\/strong><\/p>\n

            \n
          1. \u5c71\u4e0b\u3000\u7be4. \u52d5\u8108\u8840\u6813\u75c7\u306e\u75c5\u7406\u3068\u75c5\u614b\uff1a\u30d5\u30a9\u30f3\u30a6\u30a3\u30eb\u30d6\u30e9\u30f3\u30c9\u56e0\u5b50\u306e\u95a2\u4e0e (\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff1aTTP\u306e\u75c5\u614b\u3068\u65b0\u898f\u6cbb\u7642). \u7b2c72\u56de\u65e5\u672c\u8f38\u8840\u7d30\u80de\u6cbb\u7642\u5b66\u4f1a (\u6771\u4eac\u30015\/31, 2024)<\/li>\n
          2. \u9b4f\u3000\u5cfb\u6d38. Histopathological features of cancer-associated venous thromboembolism: presence of intrathrombus cancer cells and prothrombotic factors (\u5b66\u8853\u5968\u52b1\u8cde \u53d7\u8cde\u8b1b\u6f14). \u7b2c46\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a (\u91d1\u6ca2, 6\/13, 2024)<\/li>\n
          3. \u9b4f\u3000\u5cfb\u6d38. \u4eba\u4f53\u75c5\u7406\u304b\u3089\u89e3\u6790\u3059\u308b\u304c\u3093\u95a2\u9023\u9759\u8108\u8840\u6813\u585e\u6813\u75c7(\u30b9\u30dd\u30f3\u30b5\u30fc\u30c9\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0). \u7b2c17\u56deDAIICHI-SANKYO SYMPOSIUM FOR THROMBOSIS UPDATE (\u91d1\u6ca2, 6\/14, 2024)<\/li>\n
          4. \u6d45\u7530\u3000\u7950\u58eb\u90ce. \u52d5\u8108\u786c\u5316\u3068\u8840\u6813\u75c7\uff1a\u30a2\u30c6\u30ed\u30fc\u30e0\u8840\u6813\u75c7\u306b\u304a\u3051\u308b\u8840\u6813\u5f62\u6210\u6a5f\u5e8f(\u5927\u5cf6\u8cde\u53d7\u8cde\u8b1b\u6f14). 56\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a (2024.7.6-7, \u795e\u6238)\u00a0<\/li>\n
          5. \u5c71\u4e0b\u3000\u7be4. \u52d5\u8108\u786c\u5316\u6027\u75be\u60a3\u3078\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\uff1a\u30e2\u30c7\u30eb\u52d5\u7269\u304b\u3089\u30d2\u30c8\u3078 (\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff1a\u52d5\u8108\u786c\u5316\uff1a\u6cbb\u7642\u5b66\u306e\u9032\u6b69\u3068\u75c5\u7406\u5b66\u3078\u306e\u671f\u5f85). \u7b2c29\u56de\u8840\u7ba1\u75c5\u7406\u7814\u7a76\u4f1a (2024.11.23-24, \u798f\u5ca1).<\/li>\n<\/ol>\n

            \uff08\u30b9\u30e9\u30a4\u30c9\u30b3\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\uff09<\/strong><\/p>\n

              \n
            1. \u9ed2\u6728\u9ebb\u7531\uff1a\u4e0b\u984e\u816b\u760d\uff08Odontogenic carcinoma with dentinoid\uff09
              \u7b2c402\u56de\uff08Web\u767a\u8868\uff09<\/li>\n<\/ol>\n

              \uff08\u53d7\u8cde\uff09<\/strong><\/p>\n

                \n
              1. \u7b2c41\u56de\uff082024\u5e74\u5ea6\uff09\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u3000\u5927\u5cf6\u8cde
                \u6d45\u7530\u3000\u7950\u58eb\u90ce\uff08\u540d\u8a89\u6559\u6388\uff09<\/li>\n<\/ol>\n
                  \n
                1. \u7b2c29\u56de(2024\u5e74\u5ea6) \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u3000\u5b66\u8853\u5968\u52b1\u8cde
                  \u9b4f\u3000\u5cfb\u6d38<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                  \uff08\u539f\u8457\u8ad6\u6587\uff09 Otani T*, Moriguchi-Goto S*, Nishihira K, Oguri N, Shibata Y, Matsuura Y, Kodama T, Asada Y, Hatakeyama … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":96,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mi_skip_tracking":false},"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/1200"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/users\/96"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/comments?post=1200"}],"version-history":[{"count":5,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/1200\/revisions"}],"predecessor-version":[{"id":1212,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/1200\/revisions\/1212"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/media?parent=1200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}